Abstract
Human cytomegalovirus (HCMV) can cause symptomatic or asymptomatic infection in infants. One hundred and twenty-six infants were assessed clinically for disease in infantile period. Eighty of them were classified as symptomatic infection on the basis of physical, instrumental, and laboratory findings, 5 were demonstrated by following up to have later developed HCMV disease, and the other 41 infants were classified as asymptomatic infection. HCMV DNA was positive in all urine samples of the symptomatic infants detected by quantitative polymerase chain reaction. HCMV-IgM antibody detected by chemiluminescent immunoassay (CLIA) was positive in 62 of the 85 symptomatic infants, but was negative in all of the samples of asymptomatic infants. HCMV pp65 antigen detected by flow cytometry assay (FCA) was positive in 77 of the 85 symptomatic infants and in none of the asymptomatic infants. The coincidence to symptom of HCMV pp65 antigen detection was higher than those of HCMV DNA and HCMV-IgM antibody detection. The sensitivity, specificity, positive prognostic value and the negative prognostic value of HCMV pp65 antigen detection for diagnosis of HCMV infection was 90.6, 100, 100 and 83.7%, respectively. We concluded that detection of pp65 antigen by FCA is more sensitive for diagnosis of HCMV infection than detection of HCMV-IgM antibody and is better than HCMV DNA quantification for distinguishing the symptomatic and asymptomatic HCMV infection in infants.
Similar content being viewed by others
References
Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R (2004) Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis 39:233–239. doi:10.1086/421999
Cannon MJ, Davis KF (2005) Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 5:70. doi:10.1186/1471-2458-5-70
Boeckh M, Gallez-Hawkins GM, Myerson D, Zaia JA, Bowden RA (1997) Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation 64(1):108–113. doi:10.1097/00007890-199707150-00020
Petersen E, Borobio MV, Guy E, Liesenfeld O, Meroni V, Naessens A et al (2005) European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol 43(4):1570–1574. doi:10.1128/JCM.43.4.1570-1574.2005
Gerna G, Revello MG, Percivalle E, Morina F (1992) Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 30:1232
Ghisetti V, Barbui A, Donegani E, Bobbio M, Caimmi P, Pansini S et al (1996) Comparison of polymerase chain reaction and pp65 antigen test for early detection of human cytomegalovirus in blood leukocytes of cardiac transplant recipients. Clin Microbiol Infect 1:195. doi:10.1111/j.1469-0691.1996.tb00553.x
Laskin OL, Stahl-bayliss CM, Kalman CM, Rosecan LR (1999) Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected infants. J Clin Virol 14(1):57–66. doi:10.1016/S1386-6532(99)00016-5
Masharry JJ (1994) Uses of flow cytometry in virology. Clin Microbiol Rev 7:576
Ploem-Zaaijer JJ, Mesker WE, Boland GJ, Sloos WC, van de Rijke FM, Jiwa M et al (1994) Automated image cytometry for detection of rare viral antigen-positive cells in peripheral blood. Cytometry 15:199. doi:10.1002/cyto.990150304
Imbert-Marcille BM, Robillard N, Poirier AS, Coste-Burel M, Cantarovich D, Milpied N et al (1997) Development of a method for direct quantification of cytomegalovirus antigenemia by flow cytometry. J Clin Microbiol 35(10):2665
Jiwa N, Mesker W, Ploem-zaaijer J, Van drop W, The T, Raap A (1994) Quantification of low frequency white blood cells expressing human cytomegalovirus antigen by image cytometry. Cytometry 16:69. doi:10.1002/cyto.990160110
Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11:93–99. doi:10.1097/00006454-199202000-00007
Sia IG, Patel R (2000) New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 13(1):83–121
Paya CV (2002) Prevention of fungal infection in transplantation. Transpl Infect Dis 4(Suppl 3):46–51. doi:10.1034/j.1399-3062.4.s3.7.x
St George K, Boyd MJ, Lipson SM, Ferguson D, Cartmell GF, Falk LH et al (2000) A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia. J Clin Microbiol 38(4):1430–1433
von Muller L, Hinz J, Bommer M, Hampl W, Kluwick S, Wiedmann M et al (2007) CMV monitoring using blood cells and plasma: a comparison of apples with oranges? Bone Marrow Transplant 39:353–357. doi:10.1038/sj.bmt.1705593
May G, Kühn JE, Eing BR (2006) Comparison of two commercially available pp65 antigenemia tests and COBAS Amplicor CMV Monitor for early detection and quantification of episodes of human CMV-viremia in transplant recipients. Intervirology 49:261–265. doi:10.1159/000093455
Kusne S, Grossi P, Irish W, St George K, Rinaldo C, Rakela J et al (1999) Cytomegalovirus pp65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipient. Transplantation 68:1125–1131. doi:10.1097/00007890-199910270-00011
Sia IG, Patel R (2000) New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 13:83–121
Kalpoe SS, Kroes ACM, de Jong MD, Schinkel J, de Brouwer CS, Beersma MFC et al (2004) Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 42:1498–1504. doi:10.1128/JCM.42.4.1498-1504.2004
Mengelle C, Pasquier C, Rostaing L, Sandres-Sauné K, Puel J, Berges L et al (2003) Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia. J Med Virol 69:225–231. doi:10.1002/jmv.10277
Nitsche A, Oswald O, Steuer N, Schetelig J, Radonić A, Thulke S et al (2003) Quantitative real-time PCR compared with pp65 antigen detection for cytomegalovirus (CMV) in 1122 blood specimens from 77 patients after allogeneic stem cell transplantation: which test better predicts CMV disease development? Clin Chem 49:1683–1685. doi:10.1373/49.10.1683
Acknowledgments
This work was supported by the National Natural Science Foundation of China (30672248), National Natural Science Foundation of China (30770109) and the Project of Doctor Foundation of Liaoning Province in China (20061039).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, Z., Ceng, X., Mao, Z. et al. Diagnostic value of HCMV pp65 antigen detection by FCA for symptomatic and asymptomatic infection: compared to quantification of HCMV DNA and detection of IgM antibody in infants. Med Microbiol Immunol 198, 107–112 (2009). https://doi.org/10.1007/s00430-009-0112-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-009-0112-y